What you should track before and after starting a GLP-1

November 19, 2026
X
4
 mins read
Nicole Pajer
WRITTEN BY
Nicole Pajer
Dr. Shannon Ashley, M.D.
MEDICAL REVIEWED BY
Dr. Shannon Ashley, M.D.
Summary

When taking a GLP-1 for weight loss, it's important to track more than just the number on the scale. Monitoring changes in your body composition, muscle strength, blood sugar, blood pressure, and cholesterol can help you better understand how your body is responding to treatment. It's also important to pay attention to your appetite, nutrition, hydration, and any side effects. Establishing a baseline before starting treatment and checking in on these measurements over time can help you and your healthcare provider determine whether adjustments to your plan, diet, or exercise routine are needed.

What you should track before and after starting a GLP-1

If you’re on a GLP-1 for weight loss, it can be easy to place your focus entirely on the number on the scale—but weight isn't the only thing worth paying attention to. Throughout your treatment, ask yourself: How is my strength? Are my blood sugar and blood pressure improving? Am I getting enough nutrients?

GLP-1 based medications support weight loss by acting on hormone pathways involved in appetite regulation, satiety (feeling full), and glucose metabolism. These effects can reduce appetite and help people consume less food. But the weight loss you experience while on these medications isn’t always just body fat. Some people taking GLP-1s also lose muscle mass and may experience key nutrient deficiencies if they aren't eating enough. 

Establishing a baseline before treatment gives you a starting point for following those changes. As treatment progresses, paying attention to your strength, eating habits and relevant health markers can keep your long-term health in focus, even when weight loss is your most immediate goal.

Related: How weight loss drugs affect your entire body

What should you measure before starting a GLP-1?

While the idea of losing fat may make you want to jump right into weight loss injections, there are some things to do first that may help you prepare for treatment. Start by scheduling an appointment with your healthcare provider to talk through your current health, any medications you're taking, and what you hope to achieve with treatment.

Your doctor may want to record your pre-treatment measurements, such as your weight, waist circumference, and blood pressure. Having these numbers to refer back to can make it easier to see how your body is reacting and changing over time. Depending on your medical history, your doctor may also suggest certain blood tests to look at your current blood sugar, cholesterol, and kidney or liver function. Your healthcare provider should also review your medical history for medication-specific contraindications, precautions, and potential interactions before treatment begins.

A 2025 joint clinical advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and the Obesity Society recommends assessing nutritional status, muscle strength, physical function, and body composition when starting GLP-1 treatment. This includes taking note of your usual eating habits, physical activity, strength, and mobility. Along with paying attention to how easily you can perform everyday activities like climbing stairs, carrying groceries, or getting up from a chair. Noticing whether these movements become easier or harder over time can give you helpful information to keep an eye on as you lose weight.

While these health metrics are a good starting point, it’s important to ask your healthcare provider which measurements they recommend monitoring based on your specific health history and goals and how often you should be checking in.

Related: Why tracking your BMI is becoming irrelevant

Why tracking body fat and muscle matters during weight loss

When you lose weight, you may lose muscle along with fat. However, research on GLP-1 medications often measures changes in lean body mass, a broader category that includes muscle, water, organs and other tissues. So when researchers report a loss of lean body mass, it doesn't mean that all of that weight came entirely from muscle.

For example, a 2021 exploratory body composition analysis from the STEP 1 trial found that participants receiving semaglutide experienced a 19.3% reduction in total fat mass and a 9.7% reduction in lean body mass from baseline over 68 weeks. While body composition tracking isn't routinely required for patients receiving GLP-1 therapy, this finding highlights its potential value, particularly alongside clinically important trends in muscle strength, physical function, nutritional status, and weight. 

Prenuvo’s Body Composition Analysis uses MRI technology to measure lower body muscle volume and symmetry, fat beneath the skin, visceral fat around internal organs, liver fat and certain abdominal organ volumes. An initial assessment provides a baseline, while repeat assessments can show how these measurements may change over time. For someone taking a GLP-1, this can offer more specific information about changes in fat and muscle than weight alone.

Related: What you get in your Body Composition Analysis Report

Some research suggests GLP-1 medications may also help reduce liver fat. A 2025 clinical trial found that semaglutide improved liver disease outcomes in people with a more advanced form of fatty liver disease, known as metabolic dysfunction-associated steatohepatitis (MASH).

Body composition results can offer more insight when paired with how you feel and move in daily life. Changes in muscle volume, for example, can help guide conversations with your healthcare provider about strength training, nutrition and whether additional evaluation would be helpful.

Ask your doctor whether a body composition analysis or follow-up assessment may be beneficial based on your individual health factors and goals.

Related: Why you should be tracking your body composition

How can you tell if you're losing muscle strength?

While body composition measurements can show how much muscle you have in certain areas, they don't necessarily tell you how strong you are or how well your muscles are functioning. That's why it's also worth keeping track of your strength as you lose weight.

For example, are you having trouble lifting the same amount of weight during your workouts? Do you tire more easily during activities that used to feel manageable? These could be signs that you're losing strength. It’s a good idea to discuss these changes with your healthcare provider, even if your muscle-volume measurements haven't changed significantly.

Preserving muscle is an important consideration during weight loss, including when taking a GLP-1 medication. Resistance training, such as lifting weights or using resistance bands, can help support muscle retention, and getting enough protein plays a role.

Stanford Medicine notes that some adults who are actively losing weight may benefit from more protein than the recommended dietary allowance of 0.8 grams per kilogram of body weight. Individual needs vary, and protein alone does not replace the benefits of strength training. Your healthcare provider or a registered dietitian can help you determine a protein target that reflects your health history, nutritional needs and activity level.

Related: How to maintain muscle and strength as you age

Which health markers should you monitor while taking a GLP-1?

Health metrics like your blood sugar, blood pressure, and cholesterol can also change while you're taking a GLP-1. Throughout your GLP-1 journey, your doctor may want to monitor these numbers to see how you're responding to treatment.

People with type 2 diabetes, for example, may need to monitor their blood sugar more closely during treatment, especially if they also take insulin or other diabetes medications. If you start your treatment with high blood pressure or high cholesterol, your doctor may also want to see whether those numbers improve as you lose weight. 

How often you need to check these numbers depends on your health, which GLP-1 medication you're taking, and any other medications you use. 

Related: What your bloodwork says about your health

Routine bloodwork varies depending on what your healthcare provider orders. Common tests include a complete blood count (CBC), which measures different types of blood cells; a comprehensive metabolic panel (CMP), which assesses blood sugar, electrolytes and markers of kidney and liver health; and a lipid panel, which measures cholesterol and triglycerides. However, more specialized testing for nutrient levels, such as vitamin B12, vitamin D, and ferritin, as well as hormone levels and additional cardiovascular markers like ApoB and Lp(a), generally requires separate orders.

Prenuvo offers three levels of blood biomarker testing, with each panel building on foundational measurements to provide additional insight into different aspects of health. The Core Panel assesses markers related to blood health, metabolism and organ function, including kidney and liver health. The Comprehensive Panel expands on this foundation with additional testing for blood sugar regulation (HbA1c), thyroid function (TSH) and cholesterol levels through a basic lipid panel. The Executive Panel offers the most extensive assessment, measuring 90+ biomarkers across areas including cardiovascular health, insulin resistance, inflammation, hormone balance and nutrient status. Additional measurements include vitamin B12, folate, vitamin D, magnesium and iron studies, including ferritin. Hormone testing also varies by sex, with the panel including markers such as estrogen, progesterone, FSH and LH for women, and additional androgen-related markers for men.

Beyond its core blood panels, Prenuvo offers additional testing for people interested in exploring specific aspects of their health. For those taking GLP-1 medications, two potentially relevant options include the CardioMetabolic Panel, which provides additional insight into cardiovascular and metabolic health, and the Nutrient Panel, which assesses selected nutrient levels. These tests may offer useful context depending on your health history, dietary intake and treatment goals. Ask your healthcare provider whether additional testing is appropriate for you.

When paired with MRI findings, these results offer complementary perspectives on health: imaging provides insight into organ structure and potential abnormalities, while bloodwork adds information about how certain biological systems are functioning. Together, they can help provide additional context for conversations with your healthcare provider and support monitoring changes over time.

Related: What happens when you combine whole body MRI and blood work?

Beyond the scale: Monitoring nutrition, appetite and side effects

As treatment progresses, notice whether a reduced appetite or gastrointestinal side effects are affecting your ability to eat and drink enough. Track changes in meal sizes, hydration and symptoms such as nausea, vomiting, constipation or diarrhea. Persistent or severe upper abdominal pain, especially with fever or jaundice, also warrants prompt medical evaluation because gallbladder problems can occur during treatment.

Note when symptoms begin and whether they appear or worsen after a dose increase. Share these observations with your healthcare provider to help guide any adjustments to your care.

Some symptoms like persistent vomiting or diarrhea require more prompt medical attention, as they can lead to dehydration and, in some cases, kidney problems. The FDA's prescribing information for Wegovy, warns that dehydration caused by gastrointestinal side effects can lead to acute kidney injury. Contact your healthcare provider if you notice these types of symptoms or you're having trouble keeping fluids down. Seek immediate care for severe or persistent abdominal pain, especially if it spreads to your back, which can be a sign of pancreatitis.

Why it's important to reassess your health throughout treatment

As your GLP-1 treatment progresses, it's worth looking back at where you started. Comparing your starting weight, body composition, strength, and metabolic markers with later results can show how you're responding to treatment. This can be especially useful when you're adjusting your dose, transitioning to maintenance, or making other changes with your prescribing clinician.

Once you've had a Prenuvo Body Composition Analysis, any future scans can be a useful comparison. Prenuvo reports are designed to be easy to access and share with your doctor, who can review the findings alongside your lab results, symptoms, and other changes in your health when taking a GLP-1.

How can you get a detailed picture of your health while taking a GLP-1?

Starting a GLP-1 can have health benefits like weight loss and improved blood sugar control, but it’s also important to make sure you're getting the nutrition and support you need while on treatment. Prenuvo offers several ways to learn more about your body composition and certain health markers, which can provide additional information to discuss with your doctor as you 

Prenuvo’s Body Composition Analysis can provide measurements of fat distribution and lower body muscle volume, while blood panels offer information about selected metabolic and nutritional markers. These assessments may complement the measurements collected during routine care, depending on your individual needs.

If starting treatment has also prompted a broader interest in your long-term health, Prenuvo’s Whole Body Scan offers detailed MRI images of major organs and structures, including the brain and spine, without ionizing radiation. It may help identify certain abnormalities that are not yet causing noticeable symptoms. This is an optional proactive screening assessment, separate from GLP-1 monitoring, and does not replace recommended screenings or follow-up with your prescribing clinician.

Related: What happens when you combine whole body MRI and blood work

Interested in learning more? Book a call with Prenuvo's Patient Services Team to explore Body Composition Analysis, Blood Panels, Whole Body Scan, and other offerings.

FAQ

What should you monitor while taking a GLP-1 for weight loss?

In addition to your weight, it's helpful to track changes in your body composition, muscle strength, blood sugar, blood pressure, and cholesterol. You should also pay attention to your appetite, nutrition, hydration, and any side effects. Your healthcare provider can help you decide which measurements are most relevant to your health goals.

‍

‍

Can GLP-1 medications cause muscle loss?

Yes, some people lose muscle while taking GLP-1 medications for weight loss. But not all weight lost is muscle. Research often measures changes in lean body mass, which includes muscle, water, and organs. Eating enough protein and incorporating resistance training into your routine can help preserve muscle as you lose weight.

‍

Which blood tests should you consider while taking a GLP-1?

Your healthcare provider may recommend blood tests to monitor your blood sugar, cholesterol, and kidney or liver function. Which tests you need and how often you should have them depends on your medical history, the medication you're taking, and any other health conditions you have.

How can you measure changes in body fat and muscle while taking a GLP-1?

A body composition analysis can provide information about changes in fat and muscle that a regular scale can't show. For example, Prenuvo's MRI-based Body Composition Analysis measures lower body muscle volume, visceral fat, and liver fat. Ask your healthcare provider whether this type of assessment would be useful for you.

How often should you check your health markers during GLP-1 treatment?

The frequency of monitoring depends on your health history, treatment goals, and medication. Your doctor may recommend checking certain measurements before starting treatment and again during follow-up appointments, particularly when adjusting your dose. You should also report persistent side effects or changes in your strength or ability to eat and drink enough.

Citations

American Heart Association. (n.d.). How to get your cholesterol tested. https://www.heart.org/en/health-topics/cholesterol/about-cholesterol/how-to-get-your-cholesterol-tested

American Heart Association. (2025, approximately). ApoB: Another look at heart disease risk. https://www.heart.org/en/health-topics/cholesterol/how-to-get-your-cholesterol-tested/apolipoprotein-b 

Association for Diagnostics & Laboratory Medicine. (n.d.). Vitamin B12. https://myadlm.org/science-and-research/scientific-resources/clinical-chemistry-trainee-council/ccb-vitamin-b12

Brennan, D. (2025, August 14). Pros and cons of GLP-1 agonists for weight loss. Mayo Clinic Health System. https://communityhealth.mayoclinic.org/featured-stories/weight-loss-drugs

Cleveland Clinic. (n.d.). GLP-1 diet guidance. https://my.clevelandclinic.org/watch/glp-1-diet

Hendley, J. (2026, March 18). Study: Taking GLP-1 drugs may increase risk of key nutrient deficiencies. Harvard Health Publishing. https://www.health.harvard.edu/diet-and-nutrition/study-taking-glp-1-drugs-may-increase-risk-of-key-nutrient-deficiencies

Mayo Clinic Diet. (2024, September 25). Managing common side effects from weight-loss drugs. https://diet.mayoclinic.org/us/blog/managing-common-side-effects-from-weight-loss-drugs

MedlinePlus. (n.d.). Complete blood count (CBC). U.S. National Library of Medicine. https://medlineplus.gov/lab-tests/complete-blood-count-cbc/

MedlinePlus. (n.d.). Comprehensive metabolic panel (CMP). U.S. National Library of Medicine. https://medlineplus.gov/lab-tests/comprehensive-metabolic-panel-cmp/

MedlinePlus. (n.d.). Ferritin blood test. U.S. National Library of Medicine. https://medlineplus.gov/lab-tests/ferritin-blood-test/

Mozaffarian, D., Agarwal, M., Aggarwal, M., Alexander, L., Apovian, C. M., Bindlish, S., Bonnet, J., Butsch, W. S., Christensen, S., Gianos, E., Gulati, M., Gupta, A., Horn, D., Kane, R. M., Saluja, J., Sannidhi, D., Stanford, F. C., & Callahan, E. A. (2025). Nutritional priorities to support GLP-1 therapy for obesity: A joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society. The American Journal of Clinical Nutrition, 122(1), 344–367. https://doi.org/10.1016/j.ajcnut.2025.04.023

National Heart, Lung, and Blood Institute. (2024, April 17). Blood cholesterol. https://www.nhlbi.nih.gov/health/blood-cholesterol

National Library of Medicine. (n.d.). Vitamin B12 level. MedlinePlus Medical Encyclopedia. https://medlineplus.gov/ency/article/003705.htm 

Sanyal, A. J., Newsome, P. N., Kliers, I., Østergaard, L. H., Long, M. T., Kjær, M. S., Cali, A. M. G., Bugianesi, E., Rinella, M. E., Roden, M., & Ratziu, V. (2025). Phase 3 trial of semaglutide in metabolic dysfunction–associated steatohepatitis. The New England Journal of Medicine, 392(21), 2089–2099. https://doi.org/10.1056/NEJMoa2413258

Stanford Medicine. (2026, March 25). How much protein should we really be eating? Five things to know. https://med.stanford.edu/news/insights/2026/03/how-much-protein.html

U.S. Food and Drug Administration. (2026, June). Wegovy (semaglutide) prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/215256s025lbl.pdf

UC Davis Health. (2025, December 5). UC Davis Health examines systemic impact of GLP-1–based therapies. https://health.ucdavis.edu/news/headlines/uc-davis-health-examines-systemic-impact-of-glp-1based-therapies/2025/12

U.S. Preventive Services Task Force. (2021, April 13). Vitamin D deficiency in adults: Screening. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/vitamin-d-deficiency-screening

Wilding, J. P. H., Batterham, R. L., Calanna, S., Van Gaal, L. F., McGowan, B. M., Rosenstock, J., Tran, M. T. D., Wharton, S., Yokote, K., Zeuthen, N., & Kushner, R. F. (2021). Impact of semaglutide on body composition in adults with overweight or obesity: Exploratory analysis of the STEP 1 study. Journal of the Endocrine Society, 5(Supplement_1), A16–A17. https://doi.org/10.1210/jendso/bvab048.030

Share this

Related articles

How your spine changes with age
November 13, 2026
How military service can shape veterans’ long-term health
November 9, 2026
How daylight saving affects your body
November 2, 2026

Stay updated on our
latests findings and research

a profile photo a of a man thinking
Open modal